Oscillating Positive Expiratory Pressure OPEP Devices

Oscillating Positive Expiratory Pressure OPEP Devices Market Outlook

The global Oscillating Positive Expiratory Pressure (OPEP) Devices Market is projected to reach approximately USD 1.5 billion by 2035, growing at a compound annual growth rate (CAGR) of around 6.5% during the forecast period from 2025 to 2035. This growth trajectory is primarily driven by an increasing prevalence of chronic respiratory diseases, such as Chronic Obstructive Pulmonary Disease (COPD) and asthma, which necessitate effective management solutions. Additionally, the growing awareness regarding the benefits of OPEP devices among healthcare professionals and patients alike is further propelling market expansion. The shift towards home healthcare due to rising healthcare costs and the convenience of at-home treatments also acts as a significant growth factor for the OPEP devices market. Furthermore, advancements in technology leading to the development of more user-friendly and effective devices are expected to complement market growth in the coming years.

Growth Factor of the Market

Several key factors are contributing to the growth of the Oscillating Positive Expiratory Pressure (OPEP) devices market. Firstly, the increasing incidence of respiratory disorders, particularly in aging populations, has necessitated the development of efficient therapeutic devices that can aid in mucus clearance and improve respiratory function. Secondly, the ongoing technological advancements in OPEP devices, such as the integration of smart technologies and enhanced portability, have made these devices more appealing to both patients and healthcare providers. Moreover, the rising trend towards outpatient care and the growing preference for home-based treatments further fuel the demand for OPEP devices. Educational initiatives and promotional campaigns by manufacturers to raise awareness regarding the significance of respiratory health are also noteworthy factors contributing to market growth. Lastly, favorable reimbursement policies in several regions are expected to bolster the adoption of these devices, making them more accessible to patients.

Key Highlights of the Market

• The market is projected to reach USD 1.5 billion by 2035.
• Expected CAGR of 6.5% from 2025 to 2035.
• Significant growth driven by respiratory disease prevalence.
• Technological advancements enhancing device effectiveness.
• Increasing trend towards home healthcare solutions.

By Product Type

Mechanical OPEP Devices:

Mechanical OPEP devices represent a significant segment within the OPEP devices market. These devices utilize a straightforward mechanism that provides positive expiratory pressure during exhalation, thereby assisting in the movement of mucus up through the airways. The simplicity and reliability of mechanical devices make them a preferred choice for many patients, especially those who may struggle with more complex devices. They are typically more affordable compared to electronic options, which increases patient access. Mechanical OPEP devices are particularly popular in clinical settings, such as hospitals and outpatient clinics, where effective management of respiratory conditions is crucial. Their reliability and ease of use contribute to favorable patient compliance, further solidifying their position in the market.

Acoustic OPEP Devices:

Acoustic OPEP devices utilize sound waves to create oscillations during exhalation, facilitating mucus clearance from the lungs. This innovative approach allows for a more efficient and less strenuous method of airway clearance, making it particularly beneficial for patients with severe respiratory conditions. The acoustic vibrations generated by these devices help to loosen mucus, making it easier to expel. As awareness of acoustic OPEP technology grows, alongside clinical evidence supporting its efficacy, this segment is anticipated to expand rapidly. The compact nature of many acoustic devices also makes them ideal for home use, catering to the increasing preference for at-home healthcare solutions.

Manual OPEP Devices:

Manual OPEP devices are designed to provide airway clearance through user-controlled exhalation techniques. These devices require the patient or caregiver to actively engage in the process, which can be beneficial for learning proper breathing techniques. While they may not be as popular as mechanical or electronic options, manual OPEP devices are appreciated for their affordability and portability. This segment has been gaining traction among younger patients or those with less severe respiratory issues, where lower intensity solutions are sufficient. The simplicity of use and the ability to control the pressure exerted during exhalation make manual devices a viable choice in various settings, thus sustaining their relevance within the market.

Electronic OPEP Devices:

Electronic OPEP devices have revolutionized respiratory therapy with their integration of advanced technologies that provide real-time feedback and monitoring capabilities. These devices often come with built-in sensors that can measure exhalation parameters, offering insights into a patient’s respiratory function and therapy effectiveness. The ability to connect to mobile applications further enhances user engagement and compliance, making electronic OPEP devices appealing for both patients and healthcare providers. The increasing demand for technologically advanced healthcare solutions is expected to drive significant growth in this segment, as patients increasingly seek devices that facilitate personalized therapy and improve health outcomes.

Portable OPEP Devices:

Portable OPEP devices cater to the rising demand for mobility and convenience among patients requiring respiratory therapy. These compact devices are designed for easy transport, allowing patients to continue their treatment while on the go. The portability of these devices is particularly beneficial for individuals with active lifestyles or those who travel frequently. Furthermore, portable OPEP devices often incorporate user-friendly designs that make them easy to operate without the need for extensive training. As more patients prioritize convenience in their healthcare management, the demand for portable OPEP devices is expected to surge, leading to expansion in this segment of the market.

By Application

COPD:

Chronic Obstructive Pulmonary Disease (COPD) is one of the leading applications for OPEP devices, reflecting the widespread prevalence of this condition globally. Patients with COPD often experience difficulty in clearing mucus from their airways, which can exacerbate their symptoms and lead to further respiratory complications. OPEP devices play a critical role in facilitating mucus clearance, improving lung function, and reducing the frequency of exacerbations. As awareness of the importance of effective respiratory management grows, the use of OPEP devices in treating COPD patients is expected to increase significantly. Additionally, healthcare providers are increasingly recommending these devices as part of comprehensive COPD management plans.

Asthma:

Asthma is another significant application for OPEP devices, as effective management of this condition often involves strategies to clear mucus and improve airway function. OPEP devices can assist asthma patients in managing their symptoms, particularly during exacerbations when mucus accumulation can worsen breathing difficulties. These devices provide a non-invasive option for airway clearance, making them an attractive choice for patients seeking to enhance their management of asthma. With rising asthma prevalence globally, the demand for OPEP devices tailored for asthma patients is expected to grow, aligning with broader efforts to improve respiratory health.

Cystic Fibrosis:

Cystic Fibrosis (CF) patients benefit significantly from using OPEP devices, as these devices help to combat the thick mucus that characterizes the condition. Regular use of OPEP devices can lead to better lung function, reduced risk of infections, and overall enhanced quality of life for individuals with CF. As healthcare providers emphasize the importance of airway clearance techniques in managing cystic fibrosis, the adoption of OPEP devices within this patient population is anticipated to rise. Ongoing research and innovation in this area are further expected to lead to the development of specialized OPEP devices designed specifically for cystic fibrosis management.

Bronchiectasis:

Bronchiectasis is a chronic condition characterized by permanent enlargement of parts of the airways, leading to mucus accumulation and recurrent infections. OPEP devices have been recognized as effective tools in managing this condition by promoting mucus clearance and improving patient outcomes. For patients with bronchiectasis, regular use of OPEP devices can lead to reduced hospitalizations and a better quality of life. As awareness of the benefits of OPEP therapy for bronchiectasis continues to grow, the market for OPEP devices aimed at this specific application is expected to expand, supported by ongoing clinical studies demonstrating their effectiveness.

Others:

A range of other applications also exists for OPEP devices, including various respiratory conditions that benefit from mucus clearance assistance. Conditions such as pneumonia, lung infections, and even some post-operative recovery scenarios can see improved outcomes with the use of OPEP devices. The versatility of these devices allows for their application across multiple patient demographics and disease states. As healthcare providers continue to explore and validate the efficacy of OPEP devices in diverse scenarios, the "Others" application segment is likely to experience growth, driven by both new clinical insights and broader adoption in non-traditional patient groups.

By Distribution Channel

Hospitals:

Hospitals are one of the primary distribution channels for OPEP devices, serving as critical healthcare facilities where respiratory treatments are routinely administered. Within hospital settings, OPEP devices are often integrated into comprehensive respiratory care programs, providing healthcare professionals with reliable tools to assist patients in managing their respiratory conditions. The availability of trained staff and the close monitoring of patient progress in hospitals make this environment ideal for the use of OPEP devices. As hospitals increasingly focus on improving patient outcomes and reducing readmission rates, the demand for effective and efficient respiratory management tools like OPEP devices is expected to rise.

Clinics:

Clinics, particularly outpatient and specialized respiratory clinics, represent an essential distribution channel for OPEP devices. These facilities frequently provide patient education and training on the use of OPEP devices, ensuring that patients are equipped with the knowledge necessary for effective self-management of their conditions. The convenience of clinics allows patients to access respiratory treatments without the need for hospital admission, thereby promoting timely interventions. With a growing emphasis on preventive care and outpatient services, the market for OPEP devices in clinics is anticipated to expand, driven by increased patient visits and proactive respiratory health management.

Online Stores:

The rise of e-commerce has led to a significant shift in the distribution of healthcare products, including OPEP devices. Online stores offer patients a convenient option to purchase OPEP devices from the comfort of their homes, often at competitive prices. This distribution channel is particularly appealing to individuals who may have mobility issues or prefer not to visit brick-and-mortar stores. Additionally, online platforms provide access to a broader range of products, including the latest innovations in OPEP technology. As online shopping continues to grow in popularity, this distribution channel is expected to play an increasingly important role in the OPEP devices market.

Retail Pharmacies:

Retail pharmacies serve as a vital distribution channel for OPEP devices, providing easy access to patients seeking respiratory management solutions. Many retail pharmacists are trained to offer guidance on the proper use of OPEP devices, ensuring that consumers have the necessary support for effective treatment. The presence of OPEP devices in retail pharmacies enhances patient convenience, allowing for immediate access to these essential devices. As pharmacies continue to expand their health and wellness offerings, the inclusion of OPEP devices in their inventory is likely to increase, further supporting patient adherence to respiratory therapy.

Others:

Other distribution channels encompass various avenues through which OPEP devices can be acquired, including specialty medical supply stores and direct sales from manufacturers. These channels may cater to a niche market of patients who seek specific products or require specialized support for their respiratory devices. The diverse nature of the "Others" category allows for flexibility in distribution strategies, enabling manufacturers and healthcare providers to reach a broader audience. As patient demand for OPEP devices continues to grow, exploring various distribution channels will be crucial in ensuring accessibility and improving overall patient care.

By Patient Age Group

Pediatric:

Pediatric patients represent a unique segment within the OPEP devices market, as children often require specialized devices tailored to their specific needs. The management of respiratory conditions in children, such as asthma and cystic fibrosis, necessitates user-friendly and safe OPEP devices that can facilitate effective treatment. Innovations in design and functionality that cater to younger patients have become increasingly important, as parents and guardians seek tools that make respiratory therapy easier and more engaging for children. The growth of this segment is driven by rising awareness among caregivers about the importance of maintaining respiratory health in pediatric populations, leading to increased adoption of OPEP devices in this age group.

Adult:

Adult patients constitute a significant portion of the OPEP devices market, as many adults suffer from chronic respiratory diseases such as COPD and asthma. The diversity of respiratory conditions prevalent among adults necessitates a range of OPEP devices to accommodate varying needs and preferences. Adults are often proactive in seeking solutions to manage their health, and the availability of effective OPEP devices has led to increased patient compliance and improved health outcomes. Moreover, the ongoing trend towards home healthcare solutions aligns with the preferences of adult patients, who increasingly favor at-home management of their respiratory conditions. This segment is expected to drive substantial growth in the OPEP devices market.

Geriatric:

The geriatric population is particularly vulnerable to respiratory diseases, making them an essential focus group for OPEP devices. Older adults often experience declines in lung function and increased mucus production, necessitating effective management tools to assist with airway clearance. The design of OPEP devices for geriatric patients must prioritize ease of use, comfort, and safety, as this demographic may have mobility limitations or other health concerns. As healthcare providers work to address the growing healthcare needs of the aging population, the demand for OPEP devices tailored for geriatric patients is expected to rise significantly, bolstered by a focus on improving quality of life and respiratory health in this group.

By Region

The regional analysis of the Oscillating Positive Expiratory Pressure (OPEP) Devices market highlights significant opportunities and growth potential across various geographical areas. North America holds a prominent position in the market due to the high prevalence of chronic respiratory diseases, increased awareness of respiratory health, and the presence of well-established healthcare infrastructure. The region is expected to account for approximately 40% of the global market share by 2035, driven by technological advancements and greater accessibility to healthcare services. Furthermore, the CAGR for North America is forecasted to be around 7% during the analysis period, emphasizing the region's dominance and robust growth prospects.

In contrast, the Asia Pacific region is projected to witness the fastest growth rate in the OPEP devices market, with a CAGR of approximately 8% from 2025 to 2035. The rapid urbanization, aging populations, and increasing healthcare investments in countries such as China and India are major contributors to this growth. The rising burden of respiratory diseases and the growing emphasis on preventive healthcare and home-based treatments are also pivotal factors driving market expansion in the region. As healthcare access improves and awareness increases, the demand for OPEP devices is expected to surge in Asia Pacific, positioning the region as a critical market for future growth.

Opportunities

There are numerous opportunities within the Oscillating Positive Expiratory Pressure (OPEP) Devices market that can be explored by stakeholders and manufacturers. One of the most significant opportunities lies in the ongoing advancements in technology, which can lead to the development of more sophisticated and effective OPEP devices. Innovations such as smart technology integration, remote monitoring capabilities, and enhanced user interfaces can cater to the evolving needs of patients, ultimately improving treatment adherence and outcomes. Additionally, the growing trend towards personalized medicine presents an opportunity to develop customized OPEP solutions tailored to the unique requirements of individual patients, further enhancing their effectiveness in managing respiratory conditions.

Moreover, increasing awareness surrounding respiratory health and the benefits of OPEP therapy presents an opportunity for manufacturers to expand their market reach through educational initiatives and strategic partnerships with healthcare providers. Collaborating with hospitals, clinics, and healthcare organizations can facilitate the introduction of OPEP devices into treatment protocols, thereby increasing adoption rates. Furthermore, targeting underserved populations, such as rural communities or low-income areas, can help bridge gaps in access to respiratory care solutions. By capitalizing on these opportunities, stakeholders can contribute to improved patient outcomes and overall growth within the OPEP devices market.

Threats

While the Oscillating Positive Expiratory Pressure (OPEP) Devices market presents numerous opportunities, it is also faced with challenges that could hinder growth. One of the primary threats is the existence of alternative therapies and devices that compete in the respiratory treatment landscape. Patients may opt for other therapeutic options, such as nebulizers or chest physiotherapy, which could limit the market share of OPEP devices. Additionally, the market is subject to stringent regulations and quality standards imposed by governmental and health authorities, making the approval process for new devices more complex and time-consuming. This regulatory burden may dissuade smaller manufacturers from entering the market, consequently stifling innovation.

Moreover, economic factors such as fluctuations in currency exchange rates and healthcare spending can also pose challenges for the OPEP devices market. Economic downturns may lead to reduced healthcare budgets, affecting the purchasing power of healthcare facilities and patients alike. These factors could lead to decreased demand for OPEP devices or pressure on prices, potentially impacting the profitability of manufacturers. To navigate these threats, companies must remain adaptable and proactive in their strategies, ensuring they can respond effectively to changing market dynamics.

Competitor Outlook

• Philips Respironics
• ResMed
• Airway Management, Inc.
• Hill-Rom Holdings, Inc.
• Hollister Incorporated
• Medtronic
• 3M Healthcare
• BD (Becton Dickinson and Company)
• Vyaire Medical, Inc.
• Dyson Ltd.
• Fisher & Paykel Healthcare Limited
• GE Healthcare
• Invacare Corporation
• Smiths Medical
• Cardinal Health

The competitive landscape of the Oscillating Positive Expiratory Pressure (OPEP) Devices market is characterized by the presence of numerous established players and emerging companies striving to capture market share. Major manufacturers such as Philips Respironics and ResMed have been at the forefront of innovation, consistently investing in research and development to enhance their product offerings. These companies are known for their comprehensive portfolios of respiratory care devices, which include OPEP devices, and their commitment to improving patient outcomes through technology. The competition is further intensified by the rapid emergence of startups and niche players that are introducing novel solutions tailored to specific patient needs, thereby increasing the overall competitive pressure in the market.

Another significant player, Medtronic, is recognized for its commitment to advancing respiratory therapy through innovative device designs and effective clinical solutions. The company focuses heavily on leveraging technology to improve patient engagement and compliance with respiratory treatments. Similarly, Fisher & Paykel Healthcare Limited has made substantial contributions to the OPEP segment, providing a range of devices aimed at enhancing patient experience and comfort. Their ongoing research into patient-specific solutions has positioned them favorably in the competitive landscape, enabling them to cater to a diverse patient demographic.

Moreover, the market is witnessing increased collaboration among manufacturers, healthcare providers, and academic institutions, aimed at optimizing treatment protocols and fostering innovation. These partnerships are pivotal in driving advancements in technology, ensuring that OPEP devices remain relevant and effective in addressing contemporary respiratory challenges. As the landscape evolves, companies that prioritize responsiveness to patient needs, invest in sustainable solutions, and foster strategic alliances are likely to thrive in the competitive OPEP devices market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 ResMed
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Medtronic
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Dyson Ltd.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 3M Healthcare
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 GE Healthcare
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Smiths Medical
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Cardinal Health
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Philips Respironics
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Invacare Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Vyaire Medical, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Hollister Incorporated
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Airway Management, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Hill-Rom Holdings, Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 BD (Becton Dickinson and Company)
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Fisher & Paykel Healthcare Limited
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Oscillating Positive Expiratory Pressure OPEP Devices Market, By Product Type
    • 6.1.1 Mechanical OPEP Devices
    • 6.1.2 Acoustic OPEP Devices
    • 6.1.3 Manual OPEP Devices
    • 6.1.4 Electronic OPEP Devices
    • 6.1.5 Portable OPEP Devices
  • 6.2 Oscillating Positive Expiratory Pressure OPEP Devices Market, By Patient Age Group
    • 6.2.1 Pediatric
    • 6.2.2 Adult
    • 6.2.3 Geriatric
  • 6.3 Oscillating Positive Expiratory Pressure OPEP Devices Market, By Distribution Channel
    • 6.3.1 Hospitals
    • 6.3.2 Clinics
    • 6.3.3 Online Stores
    • 6.3.4 Retail Pharmacies
    • 6.3.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Oscillating Positive Expiratory Pressure OPEP Devices Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Oscillating Positive Expiratory Pressure OPEP Devices market is categorized based on

By Product Type

• Mechanical OPEP Devices
• Acoustic OPEP Devices
• Manual OPEP Devices
• Electronic OPEP Devices
• Portable OPEP Devices

By Distribution Channel

• Hospitals
• Clinics
• Online Stores
• Retail Pharmacies
• Others

By Patient Age Group

• Pediatric
• Adult
• Geriatric

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Philips Respironics
• ResMed
• Airway Management, Inc.
• Hill-Rom Holdings, Inc.
• Hollister Incorporated
• Medtronic
• 3M Healthcare
• BD (Becton Dickinson and Company)
• Vyaire Medical, Inc.
• Dyson Ltd.
• Fisher & Paykel Healthcare Limited
• GE Healthcare
• Invacare Corporation
• Smiths Medical
• Cardinal Health